PRO MEDICUS LIMITED — Director's Dealing 2019

Sep 5, 2019

==> picture [162 x 34] intentionally omitted <==

Pro Medicus Limited 450 Swan Street Richmond Victoria 3121 Australia T +61 3 9429 8800 F +61 3 9429 9455 promedicus.com

6 September 2019

Company Announcement Sale of shares by Founders

Leading health imaging company Pro Medicus (ASX: PME) announced on 16 February 2018 that the Board had encouraged the founders to consider selling up to 3 million shares each, in order to improve the liquidity in the company’s shares.

Any sales were to be made in the company’s normal trading windows after the announcements of the financial results in February and August, or after the AGM in November.

In keeping with the Board’s request, on 20 March 2018 the company was advised that the founders had sold 1 million shares each.

The Board have now been advised that the founders have sold a further 1 million shares each during the current trading window.

The Board has also been advised that the founders do not intend to sell any further shares in PME before the trading period which follows our half year results in February 2020 and may not do so at that time.

For further information:

Peter Kempen AM Chairman

Pro Medicus Limited

Mr. Clayton Hatch Company Secretary Pro Medicus Limited Ph: +613 94298800

Pro Medicus Limited ABN 25 006 194 752